Home/Filings/4/0001179110-13-014659
4//SEC Filing

ACCELERON PHARMA INC 4

Accession 0001179110-13-014659

CIK 0001280600operating

Filed

Sep 25, 8:00 PM ET

Accepted

Sep 26, 4:50 PM ET

Size

16.7 KB

Accession

0001179110-13-014659

Insider Transaction Report

Form 4
Period: 2013-09-24
Maniatis Tom
Director
Transactions
  • Conversion

    Common Stock

    2013-09-24+25,108250,108 total
  • Conversion

    Common Stock

    2013-09-24+9,261259,369 total
  • Conversion

    Common Stock

    2013-09-24+5,348264,717 total
  • Conversion

    Series A Convertible Preferred Stock

    2013-09-2425,1080 total
    Common Stock (25,108 underlying)
  • Conversion

    Common Stock

    2013-09-24+714265,431 total
  • Conversion

    Series D Convertible Preferred Stock

    2013-09-247140 total
    Common Stock (714 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2013-09-249,2610 total
    Common Stock (9,261 underlying)
  • Conversion

    Series C Convertible Preferred Stock

    2013-09-245,3480 total
    Common Stock (5,348 underlying)
Footnotes (1)
  • [F1]Upon closing of the Issuer's initial public offering, each share of Series A, B, C and D Convertible Preferred Stock automatically converted into one share of Common Stock without payment of further consideration. The shares had no expiration date.

Issuer

ACCELERON PHARMA INC

CIK 0001280600

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001280600

Filing Metadata

Form type
4
Filed
Sep 25, 8:00 PM ET
Accepted
Sep 26, 4:50 PM ET
Size
16.7 KB